| CXSB2400019 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-09 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSB2400122 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | Supplementary Application | 2024-10-13 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL1400047 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(9) | New Drug Application | 2014-07-03 | 北京诺思兰德生物技术股份有限公司 | Beijing Northland Biotech Co Ltd | Certificate Issued | 2015-04-22 | view |
| CXSL1400060 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1400061 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1400063 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2015-10-29 | view |
| CXSL1600047 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(9) | New Drug Application | 2016-07-28 | 北京诺思兰德生物技术股份有限公司 | Beijing Northland Biotech Co Ltd | Certificate Issued | 2017-07-21 | view |
| CXSL1700070 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2017-08-16 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2018-05-08 | view |
| CXSL1700162 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2018-03-09 | 开封制药（集团）有限公司 | Kaifeng Pharmaceutical (GROUP) Co Ltd | Certificate Issued | 2018-09-25 | view |
| CXSL1700163 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2018-03-09 | 开封制药（集团）有限公司 | Kaifeng Pharmaceutical (GROUP) Co Ltd | Certificate Issued | 2018-09-25 | view |
| CXSL2200294 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(2.4) | New Drug Application | 2022-06-28 | | Zhuangya (Beijing) Biotechnology Co Ltd | | | view |
| CXSL2300638 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | New Drug Application | 2023-09-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2300639 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | New Drug Application | 2023-09-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2400210 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-04-03 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSS1900042 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2019-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2021-07-28 | view |
| CXSS1900043 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2019-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2021-07-28 | view |
| CXSS2000021 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2020-05-29 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2021-11-05 | view |
| CXSS2101083 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2021-12-23 | | | | | view |
| CXSS2101084 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2021-12-23 | | | | | view |
| CXSS2200013 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2022-02-07 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
